Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Can Europe's Approval And Value Reviews Work More In Concert? It's A Timesaver That Might Be A Long Time Coming

Executive Summary

In recent years, European drug approval agencies and health technology assessment authorities had little interchange, reflecting mutual disregard at best, and mutual recrimination at worst, European Medicines Agency Senior Medical Officer Hans-Georg Eichler observed.

You may also be interested in...

Projecting Market Access Success For Early-Stage Pharma Assets: Getting Past The Hurdles

All too often, pharmaceutical companies and investors put up hurdles, but they can and must identify indications and assets with high future market access potential in early stages by adjusting the early screening and evaluation process.

Industry Is Adapting To New Pricing Reality, Says GSK Chief Andrew Witty

Andrew Witty shines a positive light on value-based pricing and adds his voice to calls for harmonized HTAs across Europe.

Pharmacovigilance Feeds EMA’s Transparency Drive

The scandal surrounding the withdrawal of Servier’s diabetes drug Mediator (benfluorex) continues to rock the French medical establishment, but it also has drawn attention to the issue of regulators' transparency more broadly – including at the European Medicines Agency.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts